Drug Type ASO |
Synonyms- |
Target |
Action modulators |
Mechanism elongator acetyltransferase complex subunit 1 modulators |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Dysautonomia, Familial | Preclinical | United States | 17 Apr 2018 | |
| Dysautonomia, Familial | Preclinical | United States | 17 Apr 2018 |





